REGENERON PHARMACEUTICALS, INC. Net Income
REGENERON PHARMACEUTICALS, INC. (REGN) reported Net Income of $1.30 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement
us-gaap:NetIncomeLoss · last filed 2026-07-30
- REGENERON PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2026-06-30 was $1.30B, a 6.81% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2026-03-31 was $727.20M, a 10.08% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2025-12-31 was $844.60M, a 7.97% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2025-09-30 was $1.46B, a 8.91% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2020 was $3.51B, a 66.05% increase from fiscal 2019.
- REGENERON PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2019 was $2.12B, a 13.44% decline from fiscal 2018.
- REGENERON PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2018 was $2.44B, a 103.95% increase from fiscal 2017.
- REGENERON PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2017 was $1.20B, a 33.84% increase from fiscal 2016.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.30B 10-Q · filed 2026-07-30 | $2.02B 10-Q · filed 2026-07-30 | $2.87B derived: sum of 3 quarters · filed 2026-07-30 | $4.33B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $727.20M 10-Q · filed 2026-07-30 | $1.57B derived: sum of 2 quarters · filed 2026-07-30 | $3.03B derived: sum of 3 quarters · filed 2026-07-30 | $4.42B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $844.60M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-24 | $2.30B derived: sum of 2 quarters · filed 2026-04-24 | $3.70B derived: sum of 3 quarters · filed 2026-07-30 | $4.50B DEF 14A · filed 2026-04-24 | ||||
| 2025-09-30 | $1.46B 10-Q · filed 2025-10-28 | $2.85B derived: sum of 2 quarters · filed 2026-07-30 | $3.66B 10-Q · filed 2025-10-28 | $4.58B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $1.39B 10-Q · filed 2026-07-30 | $2.20B 10-Q · filed 2026-07-30 | $3.12B derived: sum of 3 quarters · filed 2026-07-30 | $4.46B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $808.70M 10-Q · filed 2026-07-30 | $1.73B derived: sum of 2 quarters · filed 2026-07-30 | $3.07B derived: sum of 3 quarters · filed 2026-07-30 | $4.50B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2024-12-31 | $917.70M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-24 | $2.26B derived: sum of 2 quarters · filed 2026-04-24 | $3.69B derived: sum of 3 quarters · filed 2026-04-24 | $4.41B DEF 14A · filed 2026-04-24 | ||||
| 2024-09-30 | $1.34B 10-Q · filed 2025-10-28 | $2.77B derived: sum of 2 quarters · filed 2025-10-28 | $3.49B 10-Q · filed 2025-10-28 | $4.65B derived: sum of 4 quarters · filed 2026-04-24 | ||||
| 2024-06-30 | $1.43B 10-Q · filed 2025-10-28 | $2.15B 10-Q · filed 2025-08-01 | $3.31B derived: sum of 3 quarters · filed 2026-04-24 | $4.32B derived: sum of 4 quarters · filed 2026-04-24 | ||||
| 2024-03-31 | $722.00M 10-Q · filed 2025-10-28 | $1.88B derived: sum of 2 quarters · filed 2026-04-24 | $2.89B derived: sum of 3 quarters · filed 2026-04-24 | $3.86B derived: sum of 4 quarters · filed 2026-04-24 | ||||
| 2023-12-31 | $1.16B derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-24 | $2.17B derived: sum of 2 quarters · filed 2026-04-24 | $3.14B derived: sum of 3 quarters · filed 2026-04-24 | $3.95B DEF 14A · filed 2026-04-24 | ||||
| 2023-09-30 | $1.01B 10-Q · filed 2024-10-31 | $1.98B derived: sum of 2 quarters · filed 2024-10-31 | $2.79B 10-Q · filed 2024-10-31 | $3.99B derived: sum of 4 quarters · filed 2026-04-24 | ||||
| 2023-06-30 | $968.40M 10-Q · filed 2024-10-31 | $1.79B 10-Q · filed 2024-08-01 | $2.98B derived: sum of 3 quarters · filed 2026-04-24 | $4.30B derived: sum of 4 quarters · filed 2026-04-24 | ||||
| 2023-03-31 | $817.80M 10-Q · filed 2024-10-31 | $2.01B derived: sum of 2 quarters · filed 2026-04-24 | $3.33B derived: sum of 3 quarters · filed 2026-04-24 | $4.18B derived: sum of 4 quarters · filed 2026-04-24 | ||||
| 2022-12-31 | $1.20B derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-24 | $2.51B derived: sum of 2 quarters · filed 2026-04-24 | $3.36B derived: sum of 3 quarters · filed 2026-04-24 | $4.34B DEF 14A · filed 2026-04-24 | ||||
| 2022-09-30 | $1.32B 10-Q · filed 2023-11-02 | $2.17B derived: sum of 2 quarters · filed 2023-11-02 | $3.14B 10-Q · filed 2023-11-02 | $5.37B derived: sum of 4 quarters · filed 2026-04-24 | ||||
| 2022-06-30 | $852.10M 10-Q · filed 2023-11-02 | $1.83B 10-Q · filed 2023-08-03 | $4.05B derived: sum of 3 quarters · filed 2026-04-24 | $5.69B derived: sum of 4 quarters · filed 2026-04-24 | ||||
| 2022-03-31 | $973.50M 10-Q · filed 2023-11-02 | $3.20B derived: sum of 2 quarters · filed 2026-04-24 | $4.83B derived: sum of 3 quarters · filed 2026-04-24 | $7.93B derived: sum of 4 quarters · filed 2026-04-24 | ||||
| 2021-12-31 | $2.23B derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-24 | $3.86B derived: sum of 2 quarters · filed 2026-04-24 | $6.96B derived: sum of 3 quarters · filed 2026-04-24 | $8.08B DEF 14A · filed 2026-04-24 | ||||
| 2021-09-30 | $1.63B 10-Q · filed 2022-11-03 | $4.73B derived: sum of 2 quarters · filed 2022-11-03 | $5.85B 10-Q · filed 2022-11-03 | $7.00B derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $3.10B 10-Q · filed 2022-11-03 | $4.21B 10-Q · filed 2022-08-03 | $5.36B derived: sum of 3 quarters · filed 2022-11-03 | $6.21B derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-03-31 | $1.12B 10-Q · filed 2022-11-03 | $2.26B derived: sum of 2 quarters · filed 2022-11-03 | $3.11B derived: sum of 3 quarters · filed 2022-11-03 | $4.00B derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2020-12-31 | $1.15B 10-K · filed 2021-02-08 | $1.99B derived: sum of 2 quarters · filed 2021-11-04 | $2.89B derived: sum of 3 quarters · filed 2021-11-04 | $3.51B 10-K · filed 2023-02-06 | ||||
| 2020-09-30 | $842.10M 10-Q · filed 2021-11-04 | $1.74B derived: sum of 2 quarters · filed 2021-11-04 | $2.36B 10-Q · filed 2021-11-04 | $3.16B derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $897.30M 10-Q · filed 2021-11-04 | $1.52B 10-Q · filed 2021-08-05 | $2.31B derived: sum of 3 quarters · filed 2021-11-04 | $2.98B derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-03-31 | $624.60M 10-Q · filed 2021-11-04 | $1.42B derived: sum of 2 quarters · filed 2021-11-04 | $2.09B derived: sum of 3 quarters · filed 2021-11-04 | $2.28B derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2019-12-31 | $792.00M 10-K · filed 2021-02-08 | $1.46B derived: sum of 2 quarters · filed 2021-02-08 | $1.65B derived: sum of 3 quarters · filed 2021-02-08 | $2.12B 10-K · filed 2022-02-07 | ||||
| 2019-09-30 | $669.60M 10-K · filed 2021-02-08 | $862.70M derived: sum of 2 quarters · filed 2021-02-08 | $1.32B 10-Q · filed 2020-11-05 | $2.14B derived: sum of 4 quarters · filed 2021-02-08 | ||||
| 2019-06-30 | $193.10M 10-K · filed 2021-02-08 | $654.20M 10-Q · filed 2020-08-05 | $1.47B derived: sum of 3 quarters · filed 2021-02-08 | $2.07B derived: sum of 4 quarters · filed 2021-02-08 | ||||
| 2019-03-31 | $461.10M 10-K · filed 2021-02-08 | $1.28B derived: sum of 2 quarters · filed 2021-02-08 | $1.88B derived: sum of 3 quarters · filed 2021-02-08 | $2.43B derived: sum of 4 quarters · filed 2021-02-08 | ||||
| 2018-12-31 | $820.40M 10-K · filed 2020-02-07 | $1.42B derived: sum of 2 quarters · filed 2020-02-07 | $1.97B derived: sum of 3 quarters · filed 2020-02-07 | $2.44B 10-K · filed 2021-02-08 | ||||
| 2018-09-30 | $594.70M 10-K · filed 2020-02-07 | $594.65M 10-Q · filed 2018-11-06 | $1.15B derived: sum of 2 quarters · filed 2020-02-07 | $1.62B 10-Q · filed 2019-11-05 | $1.62B 10-Q · filed 2018-11-06 | $1.80B derived: sum of 4 quarters · filed 2020-02-07 | ||
| 2018-06-30 | $551.40M 10-K · filed 2020-02-07 | $551.41M 10-Q · filed 2018-08-02 | $1.03B 10-Q · filed 2019-08-06 | $1.03B 10-Q · filed 2018-08-02 | $1.20B derived: sum of 3 quarters · filed 2020-02-07 | $1.59B derived: sum of 4 quarters · filed 2020-02-07 | ||
| 2018-03-31 | $478.00M 10-K · filed 2020-02-07 | $477.98M 10-Q · filed 2018-05-03 | $651.50M derived: sum of 2 quarters · filed 2020-02-07 | $1.04B derived: sum of 3 quarters · filed 2020-02-07 | $1.43B derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2017-12-31 | $173.50M 10-K · filed 2019-02-07 | $173.52M 10-K · filed 2018-02-08 | $561.80M derived: sum of 2 quarters · filed 2019-02-07 | $949.50M derived: sum of 3 quarters · filed 2019-02-07 | $1.20B 10-K · filed 2020-02-07 | $1.20B 10-K · filed 2018-02-08 | ||
| 2017-09-30 | $388.30M 10-K · filed 2019-02-07 | $388.32M 10-Q · filed 2017-11-08 | $776.00M derived: sum of 2 quarters · filed 2019-02-07 | $1.02B 10-Q · filed 2018-11-06 | $1.28B derived: sum of 4 quarters · filed 2019-02-07 | |||
| 2017-06-30 | $387.70M 10-K · filed 2019-02-07 | $387.74M 10-Q · filed 2017-08-03 | $636.67M 10-Q · filed 2018-08-02 | $889.72M derived: sum of 3 quarters · filed 2019-02-07 | $1.15B derived: sum of 4 quarters · filed 2019-02-07 | |||
| 2017-03-31 | $248.90M 10-K · filed 2019-02-07 | $248.93M 10-Q · filed 2017-05-04 | $502.01M derived: sum of 2 quarters · filed 2019-02-07 | $766.82M derived: sum of 3 quarters · filed 2019-02-07 | $963.04M derived: sum of 4 quarters · filed 2019-02-07 | |||
| 2016-12-31 | $253.12M 10-K · filed 2018-02-08 | $517.92M derived: sum of 2 quarters · filed 2018-02-08 | $714.14M derived: sum of 3 quarters · filed 2018-02-08 | $895.50M 10-K · filed 2019-02-07 | $895.52M 10-K · filed 2017-02-09 | |||
| 2016-09-30 | $264.80M 10-K · filed 2018-02-08 | $461.02M derived: sum of 2 quarters · filed 2018-02-08 | $642.41M 10-Q · filed 2017-11-08 | $797.40M derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-06-30 | $196.22M 10-K · filed 2018-02-08 | $377.60M 10-Q · filed 2017-08-03 | $532.60M derived: sum of 3 quarters · filed 2018-02-08 | $743.00M derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-03-31 | $181.38M 10-K · filed 2018-02-08 | $165.74M 10-Q · filed 2016-05-05 | $336.38M derived: sum of 2 quarters · filed 2018-02-08 | $546.78M derived: sum of 3 quarters · filed 2018-02-08 | $741.42M derived: sum of 4 quarters · filed 2018-02-08 | |||
| 2015-12-31 | $154.99M 10-K · filed 2017-02-09 | $365.39M derived: sum of 2 quarters · filed 2017-02-09 | $560.03M derived: sum of 3 quarters · filed 2017-02-09 | $636.06M 10-K · filed 2018-02-08 | ||||
| 2015-09-30 | $210.40M 10-K · filed 2017-02-09 | $405.04M derived: sum of 2 quarters · filed 2017-02-09 | $481.06M 10-Q · filed 2016-11-04 | $571.16M derived: sum of 4 quarters · filed 2017-02-09 | ||||
| 2015-06-30 | $194.64M 10-K · filed 2017-02-09 | $270.66M 10-Q · filed 2016-08-04 | $360.76M derived: sum of 3 quarters · filed 2017-02-09 | $444.13M derived: sum of 4 quarters · filed 2017-02-09 | ||||
| 2015-03-31 | $76.02M 10-K · filed 2017-02-09 | $166.12M derived: sum of 2 quarters · filed 2017-02-09 | $249.49M derived: sum of 3 quarters · filed 2017-02-09 | $345.84M derived: sum of 4 quarters · filed 2017-02-09 | ||||
| 2014-12-31 | $90.09M 10-K · filed 2016-02-11 | $110.18M 10-K · filed 2015-02-12 | $173.47M derived: sum of 2 quarters · filed 2016-02-11 | $269.82M derived: sum of 3 quarters · filed 2016-02-11 | $338.13M 10-K · filed 2017-02-09 | $348.07M 10-K · filed 2015-02-12 | ||
| 2014-09-30 | $83.38M 10-K · filed 2016-02-11 | $79.72M 10-Q · filed 2014-11-04 | $179.73M derived: sum of 2 quarters · filed 2016-02-11 | $248.03M 10-Q · filed 2015-11-04 | $237.90M 10-Q · filed 2014-11-04 | $344.84M derived: sum of 4 quarters · filed 2016-02-11 | ||
| 2014-06-30 | $96.35M 10-K · filed 2016-02-11 | $92.73M 10-Q · filed 2014-08-05 | $164.66M 10-Q · filed 2015-08-04 | $158.18M 10-Q · filed 2014-08-05 | $261.46M derived: sum of 3 quarters · filed 2016-02-11 | $402.77M derived: sum of 4 quarters · filed 2016-02-11 | ||
| 2014-03-31 | $68.31M 10-K · filed 2016-02-11 | $65.44M 10-Q · filed 2014-05-08 | $165.11M derived: sum of 2 quarters · filed 2016-02-11 | $306.42M derived: sum of 3 quarters · filed 2016-02-11 | $393.79M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2013-12-31 | $96.81M 10-K · filed 2015-02-12 | $238.11M derived: sum of 2 quarters · filed 2015-02-12 | $325.49M derived: sum of 3 quarters · filed 2015-02-12 | $413.74M 10-K · filed 2016-02-11 | $424.36M 10-K · filed 2014-02-13 | |||
| 2013-09-30 | $141.31M 10-K · filed 2015-02-12 | $228.68M derived: sum of 2 quarters · filed 2015-02-12 | $327.56M 10-Q · filed 2014-11-04 | $797.96M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-06-30 | $87.38M 10-K · filed 2015-02-12 | $186.25M 10-Q · filed 2014-08-05 | $656.66M derived: sum of 3 quarters · filed 2015-02-12 | $848.13M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-03-31 | $98.87M 10-K · filed 2015-02-12 | $569.28M derived: sum of 2 quarters · filed 2015-02-12 | $760.75M derived: sum of 3 quarters · filed 2015-02-12 | $837.49M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2012-12-31 | $470.41M 10-K · filed 2014-02-13 | $661.88M derived: sum of 2 quarters · filed 2014-02-13 | $738.62M derived: sum of 3 quarters · filed 2014-02-13 | $750.27M 10-K · filed 2015-02-12 | ||||
| 2012-09-30 | $191.47M 10-K · filed 2014-02-13 | $268.21M derived: sum of 2 quarters · filed 2014-02-13 | $279.86M 10-Q · filed 2013-11-05 | $226.42M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2012-06-30 | $76.74M 10-K · filed 2014-02-13 | $88.39M 10-Q · filed 2013-08-06 | $34.95M derived: sum of 3 quarters · filed 2014-02-13 | -$27.41M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2012-03-31 | $11.65M 10-K · filed 2014-02-13 | -$41.79M derived: sum of 2 quarters · filed 2014-02-13 | -$104.16M derived: sum of 3 quarters · filed 2014-02-13 | -$166.66M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2011-12-31 | -$53.44M 10-K · filed 2013-02-15 | -$115.81M derived: sum of 2 quarters · filed 2013-02-15 | -$178.31M derived: sum of 3 quarters · filed 2013-02-15 | -$221.76M 10-K · filed 2014-02-13 | ||||
| 2011-09-30 | -$62.37M 10-K · filed 2013-02-15 | -$124.87M derived: sum of 2 quarters · filed 2013-02-15 | -$168.32M 10-Q · filed 2012-10-24 | -$182.91M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-06-30 | -$62.51M 10-K · filed 2013-02-15 | -$105.95M 10-Q · filed 2012-07-25 | -$120.55M derived: sum of 3 quarters · filed 2013-02-15 | -$154.42M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-03-31 | -$43.45M 10-K · filed 2013-02-15 | -$58.04M derived: sum of 2 quarters · filed 2013-02-15 | -$91.92M derived: sum of 3 quarters · filed 2013-02-15 | -$117.39M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2010-12-31 | -$14.60M 10-K · filed 2012-02-21 | -$48.47M derived: sum of 2 quarters · filed 2012-02-21 | -$73.95M derived: sum of 3 quarters · filed 2012-02-21 | -$104.47M 10-K · filed 2013-02-15 | ||||
| 2010-09-30 | -$33.88M 10-K · filed 2012-02-21 | -$59.35M derived: sum of 2 quarters · filed 2012-02-21 | -$89.87M 10-Q · filed 2011-10-27 | -$126.36M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-06-30 | -$25.47M 10-K · filed 2012-02-21 | -$56.00M 10-Q · filed 2011-07-28 | -$92.48M derived: sum of 3 quarters · filed 2012-02-21 | -$93.50M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-03-31 | -$30.52M 10-K · filed 2012-02-21 | -$67.01M derived: sum of 2 quarters · filed 2012-02-21 | -$68.03M derived: sum of 3 quarters · filed 2012-02-21 | -$82.96M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2009-12-31 | -$36.49M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-21 | -$37.50M derived: sum of 2 quarters · filed 2012-02-21 | -$52.44M derived: sum of 3 quarters · filed 2012-02-21 | -$67.83M 10-K · filed 2012-02-21 | ||||
| 2009-09-30 | -$1.01M 10-Q · filed 2010-10-28 | -$15.95M derived: sum of 2 quarters · filed 2010-10-28 | -$31.34M 10-Q · filed 2010-10-28 | |||||
| 2009-06-30 | -$14.94M 10-Q · filed 2010-07-28 | -$30.33M 10-Q · filed 2010-07-28 | ||||||
| 2008-12-31 | -$79.13M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |